Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 476

1.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

PMID:
19273706
2.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
3.

Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.

Bilimoria KY, Balch CM, Bentrem DJ, Talamonti MS, Ko CY, Lange JR, Winchester DP, Wayne JD.

Ann Surg Oncol. 2008 Jun;15(6):1566-76. doi: 10.1245/s10434-008-9885-2. Epub 2008 Apr 15.

PMID:
18414952
4.

Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.

Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL.

J Clin Oncol. 2005 Sep 1;23(25):6054-62.

PMID:
16135473
5.

Factors influencing the use of sentinel lymph node biopsy in the Netherlands.

Huismans AM, Niebling MG, Wevers KP, Schuurman MS, Hoekstra HJ.

Ann Surg Oncol. 2014 Oct;21(11):3395-400. doi: 10.1245/s10434-014-3764-9. Epub 2014 May 12.

PMID:
24819123
6.

Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients.

Halpern MT, Chen AY, Marlow NS, Ward E.

Ann Surg Oncol. 2009 Mar;16(3):562-70. doi: 10.1245/s10434-008-0205-7. Epub 2008 Nov 8.

PMID:
18998064
7.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
8.

Melanoma in children and the use of sentinel lymph node biopsy.

Bütter A, Hui T, Chapdelaine J, Beaunoyer M, Flageole H, Bouchard S.

J Pediatr Surg. 2005 May;40(5):797-800.

PMID:
15937817
9.

American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.

Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM 3rd.

Ann Surg Oncol. 2006 Feb;13(2):198-204. Epub 2006 Jan 19.

PMID:
16418885
10.

Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense.

Davis KG, Schriver JP, Waddell B.

Am J Surg. 2002 Aug;184(2):94-6.

PMID:
12169350
11.

Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?

Hieken TJ, Velasco JM.

Surgery. 2006 Oct;140(4):500-7; discussion 507-8.

PMID:
17011896
12.
13.

Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.

Moran DE, Smith MJ, O'Sullivan MJ, Bannon H, Crotty TB, Collins CD, Skehan SJ, O'Higgins N, McDermott EW, Evoy D, Hill AD.

Ir Med J. 2007 Apr;100(4):422-4.

PMID:
17566474
14.

The prognostic importance of sentinel lymph node biopsy in thin melanoma.

Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ 3rd.

Ann Surg Oncol. 2006 Jul;13(7):927-32. Epub 2006 May 22.

PMID:
16788753
15.

Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.

Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H.

Eur J Surg Oncol. 2004 Oct;30(8):851-6.

PMID:
15336731
16.

Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.

Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.

Ann Surg Oncol. 2007 Jun;14(6):1934-42. Epub 2007 Apr 4.

PMID:
17406951
17.

Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.

Wasif N, Gray RJ, Bagaria SP, Pockaj BA.

Melanoma Res. 2013 Aug;23(4):276-82. doi: 10.1097/CMR.0b013e32836254bd.

PMID:
23695440
18.
19.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
20.

National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.

Quan ML, Hodgson N, Lovrics P, Porter G, Poirier B, Wright FC.

Breast J. 2008 Sep-Oct;14(5):421-7. doi: 10.1111/j.1524-4741.2008.00617.x. Epub 2008 Jul 24.

PMID:
18657140

Supplemental Content

Support Center